Atlas Trials

Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric Cancer

Clinical trial NCT05348161 · UNKNOWN

Trial details

NCT number
NCT05348161
Sponsor
Peking University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
HER2 Positive Advanced Gastric Cancer
Start date
2019-01-01
Primary completion
2023-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.